These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 30320163)

  • 1. Proton Pump Inhibitors: Are They a Real Threat to the Patient?
    Xavier S; Magalhães J; Cotter J
    GE Port J Gastroenterol; 2018 Sep; 25(5):243-252. PubMed ID: 30320163
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inpatient Proton Pump Inhibitor Administration and Hospital-Acquired Clostridium difficile Infection: Evidence and Possible Mechanism.
    Wombwell E; Chittum ME; Leeser KR
    Am J Med; 2018 Mar; 131(3):244-249. PubMed ID: 29122635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased risk of fundic gland polyps during long-term proton pump inhibitor therapy.
    Jalving M; Koornstra JJ; Wesseling J; Boezen HM; DE Jong S; Kleibeuker JH
    Aliment Pharmacol Ther; 2006 Nov; 24(9):1341-8. PubMed ID: 17059515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Adverse effects of long-term proton-pump inhibitor therapy on adults].
    Igaz I; Simonyi G; Balogh S; Szathmári M
    Orv Hetil; 2018 May; 159(19):735-740. PubMed ID: 29730946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inappropriate prescribing of proton pump inhibitors in hospitalized patients.
    Reid M; Keniston A; Heller JC; Miller M; Medvedev S; Albert RK
    J Hosp Med; 2012; 7(5):421-5. PubMed ID: 22190465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proton Pump Inhibitors: Risks and Rewards and Emerging Consequences to the Gut Microbiome.
    Singh A; Cresci GA; Kirby DF
    Nutr Clin Pract; 2018 Oct; 33(5):614-624. PubMed ID: 30071147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clostridium difficile infection and proton pump inhibitors.
    Pohl JF
    Curr Opin Pediatr; 2012 Oct; 24(5):627-31. PubMed ID: 22781139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [What is the REAL long-term risk of proton pump inhibitors?].
    Ribiere S; Guillaumot MA; Barré A; Abou Ali E; Barret M; Chaussade S; Coriat R
    Presse Med; 2019 May; 48(5):503-510. PubMed ID: 30926204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The risks of long-term use of proton pump inhibitors: a critical review.
    Jaynes M; Kumar AB
    Ther Adv Drug Saf; 2019; 10():2042098618809927. PubMed ID: 31019676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic use of proton pump inhibitors, adverse events and potential biological mechanisms: A translational analysis.
    Kheloufi F; Frankel D; Kaspi E; Lepelley M; Mallaret M; Boucherie Q; Roll P; Micallef J
    Therapie; 2018; 73(3):273-281. PubMed ID: 29128115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proton pump inhibitors: Clostridium difficile infections.
    Prescrire Int; 2013 Oct; 22(142):239-40. PubMed ID: 24298587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Review article: potential gastrointestinal effects of long-term acid suppression with proton pump inhibitors.
    Laine L; Ahnen D; McClain C; Solcia E; Walsh JH
    Aliment Pharmacol Ther; 2000 Jun; 14(6):651-68. PubMed ID: 10848649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proton-pump inhibitors adverse effects: a review of the evidence and position statement by the Sociedad Española de Patología Digestiva.
    de la Coba Ortiz C; Argüelles Arias F; Martín de Argila de Prados C; Júdez Gutiérrez J; Linares Rodríguez A; Ortega Alonso A; Rodríguez de Santiago E; Rodríguez-Téllez M; Vera Mendoza MI; Aguilera Castro L; Álvarez Sánchez Á; Andrade Bellido RJ; Bao Pérez F; Castro Fernández M; Giganto Tomé F
    Rev Esp Enferm Dig; 2016 Apr; 108(4):207-24. PubMed ID: 27034082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Snapshot of proton pump inhibitors prescriptions in a tertiary care hospital in Switzerland: less is more?
    Lenoir C; El Biali M; Luthy C; Grosgurin O; Desmeules JA; Rollason V
    Int J Clin Pharm; 2019 Dec; 41(6):1634-1641. PubMed ID: 31664687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adverse effects of proton pump inhibitors: fact or fake news?
    Schubert ML
    Curr Opin Gastroenterol; 2018 Nov; 34(6):451-457. PubMed ID: 30102612
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proton pump inhibitors, adverse events and increased risk of mortality.
    Lanas-Gimeno A; Hijos G; Lanas Á
    Expert Opin Drug Saf; 2019 Nov; 18(11):1043-1053. PubMed ID: 31498687
    [No Abstract]   [Full Text] [Related]  

  • 17. Chronic kidney disease (CKD) patients are exposed to more proton pump inhibitor (PPI)s compared to non-CKD patients.
    Lee HJ; Lee H; Oh SH; Park J; Park S; Jeon JS; Noh H; Han DC; Kwon SH
    PLoS One; 2018; 13(9):e0203878. PubMed ID: 30212538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proton Pump Inhibitors and Dementia: Deciphering the Data.
    Moayyedi P; Lewis MA
    Am J Gastroenterol; 2017 Dec; 112(12):1809-1811. PubMed ID: 29215629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The inappropriate use of proton pump inhibitors during admission and after discharge: a prospective cross-sectional study.
    Sattayalertyanyong O; Thitilertdecha P; Auesomwang C
    Int J Clin Pharm; 2020 Feb; 42(1):174-183. PubMed ID: 31865594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The clinicopathological characteristics of gastric polyps and the relationship between fundic gland polyps, Helicobacter pylori infection, and proton pump inhibitors.
    Gao W; Huang Y; Lu S; Li C
    Ann Palliat Med; 2021 Feb; 10(2):2108-2114. PubMed ID: 33725768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.